Gabapentin
- Product NDC
- 67544-353
- 11-digit product format
- 675440353
- Labeler code
- 67544
- Product ID
- 67544-353_03cba200-f94b-4357-bee2-b32b12f19891
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA075350
- Marketing category
- ANDA
- Marketing start
- 2004-10-04
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 300 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 67544-353-30 | EA - Each | 67544-353 | 6aa03d62-b4dc-4a3f-b89b-8234bc2a726d | 1 | 2013-06-04 |
| 67544-353-53 | EA - Each | 67544-353 | e4c6bca8-edab-47a0-9686-6ca84b8db132 | 1 | 2013-06-04 |
| 67544-353-60 | EA - Each | 67544-353 | e1a05ed2-1101-4fb1-87fb-2f7bcfe7d6e8 | 1 | 2013-06-04 |
| 67544-353-70 | EA - Each | 67544-353 | 4336654b-ad01-42db-b6a2-59520772646e | 1 | 2013-06-04 |
| 67544-353-80 | EA - Each | 67544-353 | 7c0bb159-7fa1-49e7-8ede-359b67c48aee | 1 | 2013-06-04 |
| 67544-353-92 | EA - Each | 67544-353 | 2eecc95e-556c-46ad-90a9-588282ce783f | 1 | 2013-06-04 |
| 67544-353-94 | EA - Each | 67544-353 | 3e608ee2-b091-478f-94e1-0adf8d10900f | 1 | 2013-07-02 |
| 67544-353-98 | EA - Each | 67544-353 | 9f2f82c3-2700-4f09-a586-0f9017500e64 | 1 | 2013-07-02 |